Literature DB >> 11403726

Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.

M S Cousins1, H M Stamat, H de Wit.   

Abstract

Baclofen has been reported in uncontrolled clinical studies to reduce craving for abused drugs and reduce their rewarding effects. The objective of the present study was to measure the acute effects of a single dose of baclofen on cigarette smoking, craving for nicotine, cigarette taste, and smoking satisfaction. Tobacco smokers (n = 16) who were not trying to quit received baclofen (20 mg) or placebo after overnight abstinence during two laboratory sessions in a within-subjects design. We measured the subjective effects of baclofen on mood and self-reported ratings of craving for nicotine, and on the number of cigarettes smoked of the subjects' preferred brand during a 3-h ad libitum smoking period. Baclofen did not change the number of cigarettes smoked by the subjects nor did it change ratings of nicotine craving. However, baclofen altered the sensory properties of smoked cigarettes (e.g., increasing ratings of 'harsh' and decreasing ratings of 'like cigarette's effects'). It also produced mild sedative-like subjective effects, such as increases in feeling 'relaxed'. Thus, although baclofen did not reduce cigarette craving or smoking in the present study, it did produce some mood-altering effects and changes in sensory aspects of smoking that may facilitate smoking cessation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403726     DOI: 10.1080/14622200110042624

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  23 in total

1.  Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.

Authors:  Aryeh I Herman; Andrew J Waters; Sherry A McKee; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

Review 2.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

3.  Baclofen reduces fat intake under binge-type conditions.

Authors:  Ariel Buda-Levin; Francis H E Wojnicki; Rebecca L Corwin
Journal:  Physiol Behav       Date:  2005-09-15

4.  Longitudinal associations between people's cessation-related experiences and their satisfaction with cessation.

Authors:  Austin S Baldwin; Alexander J Rothman; Andrew W Hertel; Nora K Keenan; Robert W Jeffery
Journal:  Psychol Health       Date:  2009-02

5.  Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence.

Authors:  Joke Beuten; Jennie Z Ma; Thomas J Payne; Randolph T Dupont; Karen M Crews; Grant Somes; Nancy J Williams; Robert C Elston; Ming D Li
Journal:  Am J Hum Genet       Date:  2005-03-09       Impact factor: 11.025

6.  The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study.

Authors:  Teresa R Franklin; Derek Harper; Kyle Kampman; Susan Kildea-McCrea; Will Jens; Kevin G Lynch; Charles P O'Brien; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2009-04-23       Impact factor: 4.492

7.  Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats.

Authors:  Bernard Le Foll; Carrie E Wertheim; Steven R Goldberg
Journal:  Neurosci Lett       Date:  2008-08-05       Impact factor: 3.046

8.  Systematic assessment of gamma hydroxybutyrate (GHB) effects during and after acute intoxication.

Authors:  Susan Y Kim; Judith C Barker; Ilene B Anderson; Jo Ellen Dyer; Gillian Earnest; Paul D Blanc
Journal:  Am J Addict       Date:  2008 Jul-Aug

Review 9.  Smoking cessation therapy with varenicline.

Authors:  Uma M Mohanasundaram; Rajinder Chitkara; Ganesh Krishna
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Association and interaction analyses of GABBR1 and GABBR2 with nicotine dependence in European- and African-American populations.

Authors:  Ming D Li; Jamie E Mangold; Chamindi Seneviratne; Guo-Bo Chen; Jennie Z Ma; Xiang-Yang Lou; Thomas J Payne
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.